ResMed Share Based Compensation Trend

RMD -- USA Stock  

USD 107.03  0.90  0.83%

This module enables investors to look at ResMed various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 414.6 M, Cost of Revenue of 908.5 M or Earning Before Interest and Taxes EBIT of 530.3 M, but also many exotic indicators such as Long Term Debt to Equity of 0.6074, Calculated Tax Rate of 23.327 or PPandE Turnover of 5.5886. This module is a perfect complement to use when analyzing ResMed Valuation or Volatility. It can also complement various ResMed Technical models. Additionally take a look at analysis of ResMed Correlation with competitors.
Showing smoothed Share Based Compensation of ResMed with missing and latest data points interpolated. A component of Net Cash Flow from Operations representing the total amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
Share Based Compensation10 Years Trend
Increasing
Slightly volatile
 Share Based Compensation 
      Timeline 

Regression Statistics

Arithmetic Mean  27,991,050
Geometric Mean  24,254,783
Coefficient Of Variation  53.89
Mean Deviation  12,593,454
Median  21,838,000
Standard Deviation  15,083,844
Range  47,678,647
R Value  0.91
R Squared  0.83
Significance  0.00001713
Slope  3,519,400

ResMed Share Based Compensation Over Time

2016-12-31  46,408,000 
2017-12-31  46,408,000 
2018-12-31  54,597,647 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Upcoming Events

ResMed Upcoming Company Events
Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 27, 2017
Additionally take a look at analysis of ResMed Correlation with competitors. Please also try Portfolio Quick Import module to import or update all your transactions via one easy-to-use interface.